ロード中...
Bevacizumab in recurrent high-grade pediatric gliomas(†)
Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promise in treating recurrent adult high-grade glioma (HGG). However, there is very little data on recurrent or progressive pediatric HGG treated with bevacizumab. We report the results of a single institution e...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2940690/ https://ncbi.nlm.nih.gov/pubmed/20363768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noq033 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|